SPIROXIS
LIVE

Serial Number

79327764

Owner

Vicore Pharma AB

Attorney

Sarah J. Schneider

Filing Date

Nov 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SPIROXIS Trademark

Serial Number: 79327764 • Registration: 7021174

SPIROXIS is a trademark filed by Vicore Pharma AB on November 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Vicore Pharma AB (5 trademarks)

Kronhusgatan 11

Entity Type: 98

Trademark Details

Filing Date

November 3, 2021

Registration Date

April 11, 2023

Published for Opposition

January 24, 2023

Goods & Services

Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for use within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for treating and preventing pulmonary fibrosis, namely, idiopathic pulmonary fibrosis; pharmaceutical preparations for use in treating diffuse systemic sclerosis with lung manifestations; pharmaceutical preparations for treating infectious lung diseases; pharmaceutical preparations for treatment and prevention of covid-19

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 22, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 26, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 26, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 11, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Jan 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 24, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 26, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 1, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 1, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 29, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 28, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jan 21, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Dec 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 9, 2021 REPR